摘要
本文报道1例使用英夫利西单克隆抗体治疗克罗恩病(CD)时合并上呼吸道耐甲氧西林金黄色葡萄球菌、铜绿假单胞菌感染的病例,以提醒临床医师在应用生物制剂治疗CD时要对感染等相关并发症保持高度警惕性。
This article reports a case of Crohn′s disease(CD)with upper respiratory tract infection caused by methicillin resistant Staphylococcus aureus and Pseudomonas aeruginosa during the treatment with infliximab.It reminds the clinicians to maintain keen vigilance against infections and other treatment-related complications when using biological agents for CD patients.
作者
刘佳
梁洁
刘真真
Liu Jia;Liang Jie;Liu Zhenzhen(Department of Gastroenterology,Xijing Hospital of Digestive Diseases,Air Force Military Medical University,Xi′an 710032,China;Department of Gastroenterology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Department of Gastroenterology,Xi′an Fourth Hospital,Xi′an 710004,China)
出处
《中华炎性肠病杂志(中英文)》
2021年第2期189-190,共2页
Chinese Journal of Inflammatory Bowel Diseases